Accendra Health

Category demand is structurally recurring, tied to chronic conditions and resupply programs, which usually supports steady cash generation.

However, payer concentration and the recent termination equal to ~12 percent of 2025 revenue add a period of elevated variance through at least mid-2026. We model mid single-digit organic revenue growth once churn stabilizes, but near-term quarter-to-quarter will remain choppy as payer transitions complete.